Gene Therapy for Osteosarcoma : "In Vitro" Characterization of Five Tumor Cell Lines and Development of Treatment Models "In Vivo"

DSpace/Manakin Repository

Show simple item record

dc.contributor.author Walling, Hobart W.
dc.date.accessioned 2006-11-27T16:55:28Z
dc.date.available 2006-11-27T16:55:28Z
dc.date.issued 1995-02
dc.identifier.other 1995 .W158
dc.identifier.uri http://hdl.handle.net/2092/462
dc.description 135 leaves. Advisor: Dean A. Hoganson en
dc.description.abstract Four human osteosarcoma cell lines (MNNG, TE85, MG63, and G292) and a human-derived osteosarcoma metastatic to murine lung (MLM) were transduced "in vitro" using retroviral vectors containing the Herpes simplex thymidine kinase (HS-tk), human interleukin 2 (IL2). and B-galactosidase (BAG) genes. Each osteosarcoma cell line was stably transduced, and the HS-tk gene effectively conferred ganciclovir (GCV) susceptibility to transduced cells. Each cell line showed a bystander effect (whereby wild type tumor cells are killed by co-incubation with HS-tk positive tumor cells and GCV). MNNG cells were used to develop a series of experiments in athymic nude mice to investigate the utility of gene therapy for the treatment of experimental osteosarcomas. Subcutaneous implants of mixtures of tumor cells and HS-tk vector producer cells (vpc) resulted in the development of tumors which were completely cured upon administration of GCV. Subcutaneous implant of mixtures of transduced and wild-type cells resulted in a potent bystander effect upon administration of GCV, with complete tumor ablation when as little as ten percent of the cells were HS-tk positive. A significant anti-tumor response was seen against primary tumors comprised of unmodified cells when a secondary tumor of transduced cells was induced at a distance of one centimeter, which supports a soluble bystander factor model. The presence of IL2-transduced cells significantly improved the efficacy of treatment, suggesting a synergy between the HS-tk and IL2 gene products. A significant anti-tumor response was seen in the treatment of established osteosarcomas by the injection of HS-tk vpc. en
dc.format.extent 14075488 bytes
dc.format.mimetype application/pdf
dc.language.iso en_US
dc.publisher Drake University en
dc.relation.ispartofseries Drake University Theses, Colleges of Arts and Sciences;1995
dc.subject Osteosarcoma en
dc.subject Cell lines en
dc.subject Gene therapy en
dc.title Gene Therapy for Osteosarcoma : "In Vitro" Characterization of Five Tumor Cell Lines and Development of Treatment Models "In Vivo" en
dc.type Thesis en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account